The Food and Drug Administration (FDA) has approved the Senza Omnia Spinal Cord Stimulation (SCS) System (Nevro) for the treatment of chronic intractable pain of the trunk and/or limbs.
Fremanezumab was found to be effective and well-tolerated in patients with migraine who have failed to respond to prior preventive treatment.
Apadaz (benzhydrocodone and acetaminophen immediate-release tablets) and its authorized generic AG-Apadaz will be available nationally beginning in November 2019.
Off-label antidepressant use for chronic pain has increased in recent years in part as a result of the opioid epidemic and the need to reduce prescribing and use of opioids for chronic pain.
The authors refute a systematic review and meta-analysis of literature on greater occipital nerve block for the treatment of chronic migraine headaches by Shauly and colleagues and published in Plastic and Reconstructive Surgery, citing extensive limitations and claiming the study ultimately raises more questions than answers.
Women with vs without frequent episodic tension-type headache (TTH) may have greater nerve sensitivity in response to mechanical stimuli, according to a study in Musculoskeletal Science and Practice. In this case-control, cross-sectional analysis, 32 consecutive women with TTH and 32 age-matched control individuals without a history of headache over the previous year were recruited from…
Patients who initially see a physical therapist or chiropractor for low back pain rather than a primary care physician are much less likely to be prescribed opioids.
Ubrogepant — a small-molecule, orally delivered, and specific calcitonin gene-related peptide receptor antagonist under investigation for acute treatment of migraine — features a favorable tolerability profile in healthy adults, study results published in Cephalalgia suggest. Calcitonin gene-related peptide receptor antagonism was previously shown to be effective in the acute treatment of migraine attacks. However, the…
Company claimed their CBD products can be used to treat a variety of conditions and diseases including teething pain and earaches in infants, skin problems, autism, ADHD, Parkinson disease, and Alzheimer disease, among others.
Sleep disturbance may be associated with reduced improvements in pain interference and pain severity in patients with chronic pain, regardless of whether they are treated with opioids.
